Yuequan Shi

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Circulating Tumor

Chronic Kidney Disease

Ejection Fraction

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Qing Zhou, Xiangning Liu, Ji Li, Bing Tong, Yan Xu, Min-Jiang Chen, Xiaoyan Liu, Xiaoxing Gao, Yuequan Shi, Jing Zhao, Wei Zhong, Mengzhao Wang
Circulating tumor cells PD-L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non-small-cell lung cancer. Thoracic cancer 14 (5) (2023)
Qing Zhou, Xiangning Liu, Ji Li, Bing Tong, Yan Xu, Min-Jiang Chen, Xiaoyan Liu, Xiaoxing Gao, Yuequan Shi, Jing Zhao, Wei Zhong, Mengzhao Wang
Circulating tumor cells PD-L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non-small-cell lung cancer. Thoracic cancer (2023)
Haoran Zhang, Dongming Zhang, Jia Liu, Yuequan Shi, Xiaoyan Liu, Min-Jiang Chen, Wei Zhong, Jing Zhao, Yan Xu, Mengzhao Wang
Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC. Thoracic cancer (2023)
Qing Zhou, Xiangning Liu, Ji Li, Bing Tong, Yan Xu, Min-Jiang Chen, Xiaoyan Liu, Xiaoxing Gao, Yuequan Shi, Jing Zhao, Wei Zhong, Mengzhao Wang
Circulating tumor cells PD-L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non-small-cell lung cancer. Thoracic cancer 14 (5) (2023)
Yuequan Shi, Xiaoyan Liu, Juan Du, Dongming Zhang, Jia Liu, Min-Jiang Chen, Jing Zhao, Wei Zhong, Yan Xu, Mengzhao Wang
Circulating cytokines associated with clinical outcomes in advanced non-small cell lung cancer patients who received chemoimmunotherapy. Thoracic cancer (2021)
Yuequan Shi, Ji Li, Min-Jiang Chen, Hongsheng Liu, Dongjie Ma, Yuxiao Lin, Mengzhao Wang, Yan Xu
Sarcoidosis-like reaction after neoadjuvant pembrolizumab combined with chemotherapy mimicking disease progression of NSCLC induced encouraging discovery of pathological complete response. Thoracic cancer (2021)
Yuequan Shi, Jian Fang, Cheng-Zhi Zhou, Anwen Liu, Yan Wang, Qingwei Meng, Cuimin Ding, Bin Ai, Yangchun Gu, Yu Yao, Hong Sun, Hui Guo, Cuiying Zhang, Xia Song, Junling Li, Bei Xu, Zhiqiang Han, Meijun Song, Tingyu Tang, Peifeng Chen, Hongmin Lu, Yongjie Shui, Guangyuan Lou, Dongming Zhang, Jia Liu, Xiaoyan Liu, Xiangning Liu, Xiaoxing Gao, Qing Zhou, Min-Jiang Chen, Jing Zhao, Wei Zhong, Yan Xu, Mengzhao Wang
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China. Thoracic cancer 13 (3) (2021)
Yuequan Shi, Zhongxing Bing, Xiaohui Xu, Yushang Cui
Primary pulmonary malignant melanoma: Case report and literature review. Thoracic cancer 9 (9) (2018)
Yuequan Shi, Mengzhao Wang
Afatinib as first-line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literature. Thoracic cancer 9 (12) (2018)